Nephrotic syndrome and kidney failure due to immunocomplex-mediated renal damage in a patient with Waldenström's Macroglobulinemia: a case report
© Castro et al; licensee BioMed Central Ltd. 2008
Received: 23 October 2008
Accepted: 19 November 2008
Published: 19 November 2008
Unlike the quite frequent renal involvement seen in cases of Multiple Myeloma, the kidney is hardly ever compromised in patients with Waldenström's Macroglobulinemia. Nephrotic range proteinuria is a very unusual manifestation of renal injury in these patients and when present it is due to amyloid light-chain deposition most of the times.
A 60-year-old male patient presented to the hospital with nephrotic syndrome, renal insufficiency, hypertension and lymphadenopathy. The investigations led to the diagnosis of Waldenström's Macroglobulinemia with associated nephrotic syndrome and chronic kidney disease due to an unusual form of hypocomplementemic glomerulopathy with histopathological features similar to those seen in mesangiocapillary glomerulonephritis type III, but lacking proliferative changes.
We present an unusual case of immunologically-mediated renal damage in a patient with Waldenström's Macroglobulinemia, leading to non-amyloid nephrotic syndrome and chronic renal insufficiency.
Waldenström's Macroglobulinemia (WM) is a clonal B-cell lymphoproliferative disorder characterized primarily by bone marrow infiltration associated with IgM monoclonal gammopathy of any concentration in the serum . It is a distinct clinicopathological entity and its underlying pathological diagnosis is Lymphoplasmacytic Lymphoma (LPL) . LPL/WM is a rare lymphoid disorder accounting for only 1 to 2% of all hematologic malignancies . Although several different pathogenic mechanisms that can affect multiple organs have been described in this disease , the kidney is usually spared as compared to Multiple Myeloma and the incidence of both renal failure and nephrotic syndrome is low [3–5]. This lesser degree of renal damage has been attributed to the lower frequency and severity of Bence-Jones proteinuria and hypercalcemia. In patients with coexisting WM and kidney disease, nephrotic-range proteinuria is seen in a small percentage of cases (7 – 28%) [6, 7]. When present, the most common cause of nephrotic syndrome in these patients is AL amyloidosis [3, 8, 9]. Cases of WM with non-amyloid nephrotic syndrome are anecdotic in the worldwide literature.
A 60-year old hispanic male presented to the hospital with a six-month history of slowly progressive bilateral lower extremity edema and weight gain. His past medical history was only significant for hypertension. On physical examination the patient had a blood pressure of 208/109 mmHg, a 4+ bilateral lower extremity edema up to the thighs, and multiple palpable non-tender axillary and inguinal lymph nodes, the rest of the exam was otherwise unremarkable.
The laboratory tests yielded the following relevant values: hemoglobin 100 g/L, hematocrit 30%, and absolute lymphocytosis (6.8 × 103/μL). Urea nitrogen 19.6 mmol/L, creatinine 477 μmol/L, potassium 5.1 mmol/L, corrected calcium 2.3 mmol/L, albumin 16 g/L, total protein 40 g/L, cholesterol 6.72 mmol/L, phosphate 2.32 mmol/L, intact parathyroid hormone 360 ng/L; high erythrocyte sedimentation rate (119 mm/hr); microscopic hematuria (37 rbc/hpf) and nephrotic range proteinuria (10.3 g/24 h); ANA, ANCA, anti-DNAds and anti-GBM negative; low complement levels (C3 0.15 g/L and C4 0.02 g/L) and absent cryoglobulins. Normal IgA, low IgG (3.01 g/L) and increased IgM (9.63 g/L). Negative HBsAg, anti-HCV and HIV. Serum protein electrophoresis revealed a monoclonal spike (0.33 g/dl) and the immunofixation electrophoresis showed a monoclonal gammopathy IgM κ.
On retroperitoneal ultrasound the right kidney measured 12.4 cm, the left kidney 12.3 cm, and both showed echogenic cortex. A CT scan of the thorax, abdomen and pelvis reported multiple axillary, pelvic and retroperitoneal lymphadenopathy.
Lymph node biopsy
Abundant Congo red negative hyaline-like material was observed. Small lymphocytes with plasmacytoid appearance were identified. The lymphocytoid population was CD20+ and CD79a+ representing B cells, and it was negative for CD3, CD5, CD23, lambda and kappa. IgA, IgG and IgM immunoreactive cells were observed.
The bone marrow biopsy showed hypercellularity due to normoblastic erythroid hyperplasia consistent with a solitary large parenchymal lymphoid aggregate of small lymphocytes. The immunophenotype was consistent with an atypical B cell population and plasma cells were present by flow cytometry.
The patient was started on β-blocker and calcium channel blocker therapy for blood pressure control, Erythropoietin for anemia treatment, phosphate binder and vitamin D analog for mineral and bone disorder management, loop diuretic for volume overload treatment and subcutaneous Heparin for thromboembolic prophylaxis; no renal replacement therapy was warranted during his hospital stay. The renal function worsened over the first days of his hospitalization with a peak creatinine of 583 μmol/L, hence, in light of the laboratory and preliminary histopathologic results, a trial of steroid therapy with Prednisone 1 mg/kg/day was started at that moment in order to avoid further kidney damage with a partial positive response over the following days (decrease in creatinine to 424 μmol/L). Further immunosuppressive therapy was considered at that point, unfortunately a post-surgical infection developed following the left inguinal lymph node biopsy leading to septic shock, and in spite of aggressive management with broad-spectrum antibiotic therapy, respiratory support, fluids and vasopressors the patient expired 22 days after his hospital admission. The autopsy report did not add any pertinent information to the case.
The diagnosis of Waldenström's Macroglobulinemia has always been challenging and has evolved from the original description of a clinical syndrome to the more recent designation as a distinct clinicopathologic entity . Although significant advances have been made regarding lymphoma classification, there are no disease-defining morphological, immunophenotipic or chromosomal abnormalities specific for WM, a diagnosis can therefore be made on the basis of clinical and pathological findings . We present a patient who was found to have an IgM monoclonal gammopathy in the serum associated with lymph node and bone marrow infiltration by a small B-cell population with plasmacytic differentiation. The lymph node biopsy revealed the presence of plasmacytoid cells that expressed an immunophenotypic profile consistent with WM according to the definition criteria . The pattern of infiltration in the bone marrow was not intertrabecullar as defined by the diagnostic criteria; nevertheless, although this characteristic is considered to be helpful supporting evidence it is not the only described infiltrative pattern in cases of WM.
Renal involvement in WM is usually expressed as mild non-selective proteinuria and microscopic hematuria . The renal compromise in our patient presented as microscopic hematuria, nephrotic syndrome and chronic renal insufficiency. The nephrotic syndrome work-up was only positive for significant hypocompletemia suggesting an immunologically-mediated disorder with serum complement consumption. Amyloidosis and cryoglobulinemia were ruled out. As mentioned above, nephrotic syndrome is a rare manifestation of kidney involvement in patients with WM; in a recent case series study only 2 out of 7 patients with coexisting WM and kidney disease presented with nephrotic-range proteinuria . When present, this syndrome is usually caused by amyloidosis [3, 8, 9]; other very unusual causes include cryoglobulinemia [10, 11], minimal change disease [12, 13], intracapillary monoclonal deposit disease [7, 14] and immunocomplex-mediated glomerulonephritis [15, 16].
The usual renal histopathologic finding in WM is the presence of amorphous PAS-positive subendothelial deposits that usually occlude the capillary lumen and by electron microscopy consist of non-amyloid fibrillary material . Immunofluorescence demonstrating the presence of IgM within the glomeruli is the most commonly described pattern [3, 9, 10, 14, 17].
The histopathologic findings in our patient are similar to those originally described in MPGN type III (but lacking proliferative changes) and also often seen in proliferative lupus nephritis, but they differ from the typical pattern of renal involvement in WM in several features, firstly the absence of thrombotic deposits in the capillary lumen, secondly no fibrillary material was identified in the electron microscopy, thirdly the presence of glomerular deposits consisting of multiple immunoglobulins and complement factors instead of IgM alone, and finally the simultaneous involvement of the tunulointerstitial areas. These findings can be attributed to an immunologically mediated mechanism with deposition of immune complex and complement factors. Furthermore, the evidence of hypocomplementemia correlates well with this suggested renal insult. Similar glomerular immunofluorescence characteristics have been described in only two previous reported cases however neither had renal impairment [15, 16]. Even though the link between hematologic malignancies and glomerulonephritis has been well documented, the underlying pathogenesis in cases of WM is still unclear but it can be explained by the known intrinsic autoantibody activity of IgM .
In summary, we present a rare case of immunologically-mediated glomerulopathy associated with tubulointerstitial damage, leading to nephrotic syndrome and chronic kidney disease in a patient with LPL/WM.
Written informed consent was obtained from the patient's next of kin for publication of this case report and accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
- Owen RG, Treon SP, Al-Katib A, Fonseca R, Greipp PR, McMaster ML, Morra E, Pangalis GA, San Miguel JF, Branagan AR, Dimopoulos MA: Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. Semin Oncol. 2003, 30 (2): 110-115. 10.1053/sonc.2003.50082.View ArticlePubMedGoogle Scholar
- Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD: The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting–Airlie House, Virginia, November, 1997. Hematol J. 2000, 1 (1): 53-66. 10.1038/sj.thj.6200013.View ArticlePubMedGoogle Scholar
- Vijay A, Gertz MA: Waldenstrom macroglobulinemia. Blood. 2007, 109 (12): 5096-5103. 10.1182/blood-2006-11-055012.View ArticlePubMedGoogle Scholar
- Krajny M, Pruzanski W: Waldenstrom's macroglobulinemia: review of 45 cases. Can Med Assoc J. 1976, 114 (10): 899-900. 902, 905.PubMed CentralPubMedGoogle Scholar
- Debre P, Zittoun R, Cadiou M, Bilski-Pasquier G, Bousser J: Waldenstrom's macroglobulinemia. Developmental and prognostic study. Sem Hop. 1975, 51 (48): 2921-2925.PubMedGoogle Scholar
- Morel-Maroger L, Basch A, Danon F, Verroust P, Richet G: Pathology of the kidney in Waldenstrom's macroglobulinemia. Study of sixteen cases. N Engl J Med. 1970, 283 (3): 123-129.View ArticlePubMedGoogle Scholar
- Audard V, Georges B, Vanhille P, Toly C, Deroure B, Fakhouri F, Cuvelier R, Belenfant X, Surin B, Aucouturier P, Mougenot B, Ronco P: Renal lesions associated with IgM-secreting monoclonal proliferations: revisiting the disease spectrum. Clin J Am Soc Nephrol. 2008, 3 (5): 1339-1349. 10.2215/CJN.01600408.PubMed CentralView ArticlePubMedGoogle Scholar
- Forget BG, Squires JW, Sheldon H: Waldenstrom's macroglobulinemia with generalized amyloidosis. Arch Intern Med. 1966, 118 (4): 363-375. 10.1001/archinte.118.4.363.View ArticlePubMedGoogle Scholar
- Veltman GA, van Veen S, Kluin-Nelemans JC, Bruijn JA, van Es LA: Renal disease in Waldenstrom's macroglobulinaemia. Nephrol Dial Transplant. 1997, 12 (6): 1256-1259. 10.1093/ndt/12.6.1256.View ArticlePubMedGoogle Scholar
- Yonemura K, Suzuki T, Sano K, Fujigaki Y, Ikegaya N, Hishida A: A case with acute renal failure complicated by Waldenstrom's macroglobulinemia and cryoglobulinemia. Ren Fail. 2000, 22 (4): 511-515. 10.1081/JDI-100100892.View ArticlePubMedGoogle Scholar
- Akashi Y, Inoh M, Gamou N, Yoshimune N, Kinashi M, Ohbayashi S, Kurata N: Macroglobulinemia and membranoproliferative glomerulonephritis in a hepatitis C virus-positive patient. Clin Nephrol. 2003, 60 (1): 49-52.View ArticlePubMedGoogle Scholar
- Hory B, Saunier F, Wolff R, Saint-Hillier Y, Coulon G, Perol C: Waldenstrom macroglobulinemia and nephrotic syndrome with minimal change lesion. Nephron. 1987, 45 (1): 68-70. 10.1159/000124705.View ArticlePubMedGoogle Scholar
- Terrier B, Buzyn A, Hummel A, Deroure B, Bollee G, Jablonski M, de Serre NP, Noel LH, Fakhouri F: Serum monoclonal component and nephrotic syndrome–it is not always amyloidosis. Diagnosis: WM complicated by retroperitoneal and renal infiltration and associated with a minimal change disease. Nephrol Dial Transplant. 2006, 21 (11): 3327-3329. 10.1093/ndt/gfl467.View ArticlePubMedGoogle Scholar
- Harada Y, Ido N, Okada T, Otani M, Shirota T, Nakao T, Hayashi T: Nephrotic syndrome caused by protein thrombi in glomerulocapillary lumen in Waldenstrom's macroglobulinaemia. Br J Haematol. 2000, 110 (4): 880-883. 10.1046/j.1365-2141.2000.02259.x.View ArticlePubMedGoogle Scholar
- Martelo OJ, Schultz DR, Pardo V, Perez-stable E: Immunologically-mediated renal disease in Waldenstrom's macroglobulinemia. Am J Med. 1975, 58 (4): 567-575. 10.1016/0002-9343(75)90133-3.View ArticlePubMedGoogle Scholar
- Haraguchi S, Tomiyoshi Y, Aoki S, Sakemi T: Nephrotic syndrome due to immunologically mediated hypocomplementic glomerulonephritis in a patient of Waldenstrom's macroglobulinemia. Nephron. 2002, 92 (2): 452-455. 10.1159/000063286.View ArticlePubMedGoogle Scholar
- Tsuji M, Ochiai S, Taka T, Hishitani Y, Nagareda T, Mori H: Nonamyloidotic nephrotic syndrome in Waldenstrom's macroglobulinemia. Nephron. 1990, 54 (2): 176-178.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.